| Name | Title | Contact Details |
|---|
Lutheran Home Care & Hospice is a Chambersburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Altruista Health provides a suite of technology solutions that support collaborative, data-driven and person-centered approaches to population health management. Founded in 2007, Altruista Health has been recognized by Gartner as one of the fastest-growing care management technology companies serving complex care populations. Today, our solutions remove barriers to care, reduce avoidable healthcare expenses and improve health outcomes for more than 38 million people. Our GuidingCare™ platform is a web-based population health management system that enables health plans to maximize the value of their data and improve the quality of care for high-risk members. GuidingCare integrates data from a variety of systems, including medical and pharmacy claims, EMR/EHR, eligibility, HIEs and others, to power role-optimized workflow management tools for care coordination, quality improvement, care transitions management, utilization management, LTC/long term support services and more.
Galileo is a modern medical practice that provides full spectrum medical care, from urgent to chronic, across digital and in-person settings. They bring the best doctors to patients: at home, in the community, and on their mobile device.
LifeBrands is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.